New Shot Offers Hope for Head and Neck Cancer

A breakthrough injection treatment for head and neck cancer is delivering astonishing results: over 40% of patients saw tumor shrinkage, and 15 had complete remission. Administered simply as a monthly shot, amivantamab blocks cancer growth signals with minimal side effects—offering hope where few options remain. For HPV-negative cancers, often resistant to standard therapies, this could be a game-changer, already approved for lung cancer and now showing unprecedented promise. One patient reports living pain-free and reclaiming his life—a beacon of hope for thousands facing this devastating diagnosis. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f00e7a6060fe9fb1